about
Disruption in connexin-based communication is associated with intracellular Ca²⁺ signal alterations in astrocytes from Niemann-Pick type C miceNPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasisReduced ceramide synthase 2 activity causes progressive myoclonic epilepsyAnatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder.Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C.Cholinergic abnormalities, endosomal alterations and up-regulation of nerve growth factor signaling in Niemann-Pick type C disease.Complement is dispensable for neurodegeneration in Niemann-Pick disease type C.Lysosomal storage disorders: old diseases, present and future challenges.The unique case of the Niemann-Pick type C cholesterol storage disorder.Brain Disorders Due to Lysosomal Dysfunction.Delineating pathological pathways in a chemically induced mouse model of Gaucher disease.Lack of activation of the unfolded protein response in mouse and cellular models of Niemann-Pick type C disease.Modeling diseases in multiple mouse strains for precision medicine studies.Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology.RIPK3 as a potential therapeutic target for Gaucher's disease.Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage diseaseIs Parkinson's disease a lysosomal disorder?Lysosomal vitamin E accumulation in Niemann–Pick type C diseaseGadolinium Chloride Rescues Niemann⁻Pick Type C Liver DamageModeling Parkinson's Disease Heterogeneity to Accelerate Precision MedicineComplement Component C3 Participates in Early Stages of Niemann-Pick C Mouse Liver DamageRare diseases in Chile: challenges and recommendations in universal health coverage contextRole of proteases in dysfunctional placental vascular remodelling in preeclampsia
P50
Q27309520-D2EBA466-E875-4824-8AA7-569C0E0A8C34Q28590002-E1DE94EB-6B71-4420-9BFA-46F4E9DED043Q34418788-30E77B8A-1829-4AB5-BF8E-339C2BFD266AQ34766860-81E47AF7-5F9C-46A2-84BA-328B8849E79DQ36026905-D2EB1FFB-0691-4AD3-A8C2-386FB7C854D3Q36092402-52B2F319-EA1C-42DF-BEC5-308376ECB980Q36437350-502F502A-96F1-4AA1-AAE9-CCBFED99B46DQ38174905-62D2333A-F330-4EB5-8344-D7EA33106C9FQ38262734-8D8AA968-619E-4FB0-9ACE-037783F545B9Q38811324-6D32C686-6860-46E4-9736-C1FC36698AF6Q39730152-4600E328-462F-447A-8117-BCCF8CCA36CEQ48087919-872B7B28-06AE-4F68-B866-C09C094D103DQ48302495-BF12A916-23C0-4852-A594-485398C3AD5BQ48904695-2829DDC0-EE4A-40F3-9B76-82F8252A75AEQ54383542-A7181B31-F522-46C7-9BBF-E6A9313FA95FQ58479930-55A835A4-15F1-452A-9CBE-96F96B3F07B9Q58479932-3AD0187E-FD4A-437E-ADF4-87EE432838EBQ58479953-88FC42BF-957A-4AA3-B7FB-97314FF3A025Q59806971-50DF248B-39A1-42FD-9EF8-8E41096F5534Q91059992-B23C8577-ED0D-4987-A84C-61CF465634A7Q91545693-8245C7CA-CE2C-4970-8E1A-D816CA4C1939Q92605240-62D107B0-FF22-49F8-98BD-531710CC79F4Q92895849-A1633160-9C4A-4554-BA28-29C7FFE053E8
P50
description
researcher ORCID ID = 0000-0002-9951-2174
@en
wetenschapper
@nl
name
ANDRES KLEIN
@ast
ANDRES KLEIN
@en
ANDRES KLEIN
@es
ANDRES KLEIN
@nl
type
label
ANDRES KLEIN
@ast
ANDRES KLEIN
@en
ANDRES KLEIN
@es
ANDRES KLEIN
@nl
altLabel
adklein
@en
prefLabel
ANDRES KLEIN
@ast
ANDRES KLEIN
@en
ANDRES KLEIN
@es
ANDRES KLEIN
@nl
P108
P106
P31
P3835
andres-klein2
P496
0000-0002-9951-2174